People with Type 2 diabetes who stop taking GLP-1 medications face double the risk of heart attack, stroke or death, a study findsHealthNov 12 at 5:06 AM – Nov 12 at 4:17 PM4 outletsBloombergGLP-1 Users Skip Doses, Stretch Supply Amid Cost Pressures Nov 12 at 4:15 PMCTV NewsGLP-1 users who stop taking medication face doubled risk of heart attack, stroke or death: study seen Nov 12 at 5:06 AMFox NewsOzempic and Zepbound users face 6 rebound risks after stopping, doctor warns Nov 12 at 8:00 AMNew York PostGLP-1 users face 6 rebound risks after stopping the weight-loss drugs Nov 12 at 4:17 PM